PMID: 1203244Dec 30, 1975Paper

The mechanism of action of vinblastine. Binding of [acetyl-3H]vinblastine to embryonic chick brain tubulin and tubulin from sea urchin sperm tail outer doublet microtubules

Biochemistry
L WilsonD Chin

Abstract

Tritium-labeled viblastine, specific activity 107 Ci/mol, was prepared by acetylation of desacetylvinblastine with [3H]acetic anhydride, and has been employed in a study of vinblastine binding to tubulin. There are two high affinity vinblastine-binding sites per mole of embryonic chick brain tubulin (KA = 3-5 X 10(5) l./mol). Binding to these sites was rapid, and relatively independent of temperature between 37 and 0degreeC. Vincristin sulfate and desacetylvinblastine sulfate, two other active vinca alkaloid derivatives, competitively inhibited the binding of vinblastine. The inhibition constant for vincristine was 1.7 X 10(-5) M; and for desacetylvinblastine, 2 X 10(-5) M. The vinblastine binding activity of tubulin decayed upon aging, but this property was not studied in detail. Vinblastine did not depolymerize stable sea urchin sperm tail outer doublet microtubules, nor did it bind to these microtubules. However, tubulin solubilized from the B subfiber of the outer doublet microtubules possessed the two high affinity binding sites (KA = 1-3 X 105 l./mol). These data suggest that vinblastine destroys microtubules in cells primarily by inhibition of microtubule polymerization, and does not directly destroy preformed microtubules.

References

Jun 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·A Nagayama, S Dales
Jan 1, 1973·International Review of Cytology·L Margulis
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·B A Eipper
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R F Luduena, D O Woodward
Jan 1, 1973·Annual Review of Biochemistry·J B Olmsted, G G Borisy
Apr 10, 1973·Biochemistry·J R BamburgL Wilson
May 26, 1972·Biochemical and Biophysical Research Communications·R J OwellenD W Donigian
Jul 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·L WilsonD Mazia
Aug 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·J Bryan, L Wilson
Mar 1, 1968·Journal of Medicinal Chemistry·H F GreeniusC T Beer
Jan 1, 1969·The Journal of Cell Biology·K G Bensch, S E Malawista
Aug 1, 1969·Science·K G BenschM Shelanski
Aug 1, 1969·Science·R MarantzM Shelanski
Aug 1, 1967·The Journal of Cell Biology·G G Borisy, E W Taylor
Dec 28, 1971·Biochimica Et Biophysica Acta·M Hirose, Y Kano
Oct 8, 1962·Biochimica Et Biophysica Acta·J P HUMMEL, W J DREYER

❮ Previous
Next ❯

Citations

Jul 1, 1987·Biochemical Pharmacology·E LaceyC C Culvenor
Apr 29, 1994·Biochemical Pharmacology·R F LudueńaS Iwasaki
Aug 17, 1996·Mutation Research·M Kirsch-Volders, E M Parry
Aug 17, 1996·Mutation Research·M A JacksonM D Waters
Jan 1, 1984·Pharmacology & Therapeutics·J J Manfredi, S B Horwitz
Oct 1, 1991·Pharmacology & Therapeutics·E K Rowinsky, R C Donehower
Nov 12, 1996·Molecular and Biochemical Parasitology·R GraeserB Kappes
Jan 1, 1982·Neurochemistry International·F BraccoA Lajtha
Dec 8, 1989·Biochimica Et Biophysica Acta·G J Russell, E Lacey
May 18, 1978·The New England Journal of Medicine·Y S AhnL M Pall
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·B Bhattacharyya, J Wolff
Sep 1, 1978·Scandinavian Journal of Dental Research·H B Mikkelsen
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·D PandaL Wilson
Feb 1, 1993·Neurochemical Research·J KitanakaA Baba
Dec 1, 1986·FEBS Letters·E A UsangaL Luzzato
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·A DavisJ G Bekesi
Mar 1, 2011·Journal of Pharmaceutical and Biomedical Analysis·Dennis J MilanowskiUlla Mocek
Sep 7, 1976·Biochemical and Biophysical Research Communications·F Mandelbaum-ShavitD G Johns
Jan 1, 1984·Experimental Cell Research·J J Manfredi, S B Horwitz
Jul 25, 1982·Journal of Molecular Biology·L WilsonR L Margolis
Jan 5, 1986·Journal of Molecular Biology·M A JordanL Wilson
Mar 1, 1989·Biochemical Pharmacology·L S Borman, M E Kuehne
Jul 1, 1988·Biochemical Pharmacology·W D SingerR H Himes
Feb 1, 1984·Experimental and Molecular Pathology·Y Hirsimäki, P Hirsimäki
May 15, 1978·Journal of Molecular Biology·L Wilson, A N Morse
May 1, 1984·Journal of Neurochemistry·K F Sullivan, L Wilson
Jan 1, 1986·Annals of the New York Academy of Sciences·R F LuduenaA Fellous
Nov 22, 1976·Biochemical and Biophysical Research Communications·B Bhattacharyya, J Wolff
Mar 28, 1986·Biochemical and Biophysical Research Communications·L C BowmanP J Houghton
Feb 8, 1977·Biochemistry·F Solomon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.